Search


Current filters:
Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.033 seconds).
  • previous
  • 1
  • next
Item hits:
Issue DateTitleAuthor(s)
27-Nov-2022Comparison of the design and methodology of Phase 3 clinical trials of bictegravir/emtricitabine/tenofovir alafenamide (BIC/FTC/TAF) and dolutegravir-based dual therapy (DTG) in HIV: a systematic review of the literatureGrau, Santiago; Miró Meda, José M.; Olalla, Julián; Alcalá, Juan C.; Castro, Antonio; Rubio-Rodríguez, Darío; Rubio-Terrés, Carlos
15-Aug-2016The SAATELLITE and EVADE Clinical Studies Within the COMBACTE Consortium: A Public-Private Collaborative Effort in Designing and Performing Clinical Trials for Novel Antibacterial Drugs to Prevent Nosocomial PneumoniaFrançois, Bruno; Chastre, Jean; Eggiman, Philippe; Laterre, Pierre-François; Torres Martí, Antoni; Sanchez, Miguel; Esser, Mark T.; Bishop, Brian; Bonten, Marc; Goosens, Herman; Jafri, Hasan S.
15-Nov-2021Pre-exposure prophylaxis with hydroxychloroquine for COVID-19: a double-blind, placebo-controlled randomized clinical trial.Grau Pujol, Berta; Camprubí Ferrer, Daniel; Marti Soler, Helena; Fernández Pardos, Marc; Carreras Abad, Clara; Velasco de Andrés, María; Ferrer, Elisabet; Muelas Fernandez, Magdalena; Jullien, Sophie; Barilaro, Giuseppe; Ajanovic, Sara; Vera, Isabel; Moreno, Laura; Gonzalez Redondo, Eva; Cortes Serra, Núria; Roldán Montserrat; Artes de Arcos, Ana; Mur, Isabel; Domingo, Pere (Domingo Pedrol); Garcia Felipe; Guinovart, Caterina; Muñoz Gutiérrez, José
23-Apr-2022Existing and emerging pharmacological approaches to the treatment of mania: A critical overviewSparacino, Giulio; Verdolini, Norma; Vieta i Pascual, Eduard, 1963-; Pacchiarotti, Isabella
23-Jan-2015Reversal of rivaroxaban-induced alterations on hemostasis by different coagulation factor concentrates - In vitro studies with steady and circulating human blood -Escolar Albaladejo, Ginés; Arellano Rodrigo, Eduardo; López Vilchez, Irene; Molina, Patricia; Sanchis Forés, Juan; Reverter Calatayud, Juan Carlos; Carné Cladellas, Xavier; Cid Vidal, Joan; Villalta i Blanch, Jaume; Tàssies Penella, María Dolores; Galan, Ana M.; Diaz Ricart, M. Isabel
20-Mar-2014Reply to X. Qi et al ' Brivanib for Hepatocellular Carcinoma Trials: Selection Bias From Barcelona Clinic Liver Cancer Stage?'Llovet i Bayer, Josep Maria; Johnson, Philip J.
2014Forty-eight-week efficacy and safety and early CNS tolerability of doravirine (MK-1439), a novel NNRTI, with TDF/FTC in ART-naive HIV-positive patientsGatell, José M.; Morales Ramirez, Javier O.; Hagins, Debbie P.; Thompson, Melanie; Keikawus, Arasteh; Hoffmann, Christian; Rugina, Sorin; Osiyemi, Olayemi; Escoriu, Simona; Dretler, Robin; Harvey, Charlotte; Xu, Xia; Teppler, Hedy
11-Jun-2015A pooled analysis of overall survival in COMFORT-I and COMFORT-II, 2 randomized phase III trials of ruxolitinib for the treatment of myelofibrosis.Vannucchi, Alessandro M.; Kantarjian, Hagop M.; Kiladjian, Jean-Jacques; Gotlib, Jason; Cervantes Requena, F.; Mesa, Ruben A.; Sarlis, Nicholas J.; Peng, Wei; Sandor, Victor; Gopalakrishna, Prashanth; Hmissi, Abdel; Stalbovskaya, Viktoriya; Gupta, Vikas; Harrison, Claire N.; Verstovsek, Srdan; García Pagán, Juan Carlos
17-Jan-2020New potential weapons for refractory scleritis in the era of targeted therapyFabiani, Claudia; Sota, Jurgen; Sainz de la Maza Serra, María Teresa; Pelegrin, Laura; Emmi, Giacomo; Lopalco, Giuseppe; Iannone, Florenzo; Vannozzi, Lorenzo; Guerriero, Silvana; Gelmi, Maria Chiara; Rigante, Donato; Tosi, Gian Marco; Hernández Rodríguez, José; Cantarini, Luca